BURLINGTON, ON, Nov. 4, 2014 /CNW/ - EcoSynthetix Inc. (TSX:ECO)
("EcoSynthetix" or the "Company"), a renewable chemicals company
that produces a family of commercially proven bio-based products,
today announced its financial results for the three and nine months
ended September 30, 2014. Financial
references are in U.S. dollars unless otherwise indicated.
Third Quarter 2014 Highlights
- Net sales of $4.8 million for the
three months ended September 30,
2014, compared to $5.4 million
for the same period last year
- Won one new customer during the quarter and three new customers
YTD
- Introduced new grades of EcoSphere® paper coatings
specifically formulated for high-speed inkjet printing at
GraphExpo14
- We were awarded $2 million in
grant funding from the Bioproducts cluster program, developed by
Bioindustrial Innovation Canada, to accelerate the
commercialization of new bio-based technology platforms
- Retired 138,000 common shares ($0.2
million) during the period and 356,000 common shares
($0.7 million) year to date through
its normal course issuer bid
"Despite challenges in the paper market, our new grade of
EcoSphere biolatex has strengthened our sales pipeline with new
prospects and multiple existing customers are now using it," said
John van Leeuwen, Chief Executive
Officer of EcoSynthetix. "Our market opportunity remains as large
as ever. To achieve the growth we expect of the business, we are
focused on converting mill trials with our new paper binder grades
into customers and accelerating the commercialization of our new
products that target the wood composites and insulation
markets."
Financial Summary
Net Sales
Net sales for the three months ended September 30, 2014 (Q3 2014) were $4.8 million compared to $5.4 million for the three months ended
September 30, 2013 (Q3 2013), a
decrease of 11%. The change in sales was primarily due to a
reduction in volume of $0.9 million
due to the closure of a paper mill in North America announced by FutureMark Paper
during the current quarter, in addition to the closure of a
customer's coated paper production line in EMEA announced in the
fourth quarter of the prior year. These decreases were offset
by higher volume at existing commercial accounts.
Net sales for the year-to-date (YTD) period were $14.4 million compared to $17.1 million in the same period last year, a
decrease of 16%. The change was primarily attributable to lower
sales volumes in EMEA of $1.9 million
and Asia Pacific of $1.5 million, partly offset by an increase in
sales volume in North America of
$0.9 million. EcoSynthetix won one
new customer in the Q3 2014 and three new customers
year-to-date.
Gross Profit
Gross profit was $0.5 million or
10.2% of sales in Q3 2014 compared to $0.8
million or 15.5% in the same period last year. For the YTD
period, gross profit was $2.4 million
or 16.9% of sales compared to $2.7
million or 15.9% in the same period last year. Gross
profit in the current period was impacted by a $0.3 million charge to cost of sales related to
shipments to FutureMark Paper which were not recognized as revenue
during the third quarter since collection was not
probable.
Gross profit as a percentage of sales, adjusted for
manufacturing depreciation and the $0.3
million charge to cost of sales, was 21.2% and 24.8% for Q3
2014 and YTD, respectively, compared with 20.4% and 20.8% in the
same periods last year. The increase in gross profit during both
periods was principally due to lower manufacturing costs as a
result of lower feedstock costs partially offset by lower average
selling price.
Selling, General and Administrative
(excludes share-based compensation, depreciation and
amortization and foreign exchange loss or gain)
Selling, general and administrative (SG&A) costs were
$3.0 million and $9.0 million for Q3 2014 and YTD, respectively,
compared to $2.8 million and
$8.7 million in the corresponding
periods last year. The change in both periods was partially due to
the recognition of an allowance for doubtful accounts of
$0.4 million related to trade
receivables owing from FutureMark Paper. This was partly offset by
the favourable impact of the weakening Canadian dollar relative to
the US dollar, lower employee related costs and decreased
discretionary spending.
Research and Development
(excludes share-based compensation, depreciation and
amortization and foreign exchange loss or gain)
Research and development (R&D) costs were $1.2 million in Q3 2014, compared to $1.4 million in the same period last year. For
the YTD period, R&D costs remained comparable to last year at
$3.9 million. R&D is a key focus
of EcoSynthetix, to enhance its bio-engineered product portfolio
and expand into new applications and markets. The decrease was
primarily due to lower discretionary costs.
Adjusted EBITDA1
Adjusted EBITDA was $(3.6) million
in Q3 2014, compared to $(3.2)
million in the same period last year. For the YTD period,
adjusted EBITDA was $(9.7) million
compared to $(9.2) million in the
same period last year.
Net Loss
Net loss in Q3 2014 was $4.0
million, or $0.07 per common
share (basic and fully diluted), which was unchanged from the same
period last year. For the YTD period, net loss was $11.1 million, or $0.19 per share (basic and fully diluted)
compared to $11.1 million or
$0.20 per share (basic and fully
diluted) in the prior period.
Liquidity
Working capital was $76.8 million
at September 30, 2014 compared to
working capital of $87.3 million at
December 31, 2013. The decrease was
principally due to cash utilized in operating and investing
activities.
Notice of Conference Call
EcoSynthetix will host a conference call on Wednesday, November 5, 2014, at 8:30 AM ET to discuss its financial
results. John van Leeuwen,
CEO, and Robert Haire, CFO, will
co-chair the call. All interested parties can join the call by
dialling (647) 427-7450 or (888) 231-8191. Please dial in 15
minutes prior to the call to secure a line. A live audio webcast of
the conference call will also be available at www.ecosynthetix.com.
The presentation will be accompanied by slides, which will be
available via the webcast link and the Company's website. Please
connect at least 15 minutes prior to the conference call to ensure
adequate time for any software download that may be required to
join the webcast.
1Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures.
These non-IFRS measures are not recognized measures under IFRS, do
not have a standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. Rather, these measures are provided as
additional information to complement those IFRS measures by
providing a further understanding of results of operations of
EcoSynthetix from management's perspective. Accordingly, they
should not be considered in isolation nor as a substitute for
analysis of the financial information of EcoSynthetix reported
under IFRS. The Company uses non-IFRS measures such as Adjusted
EBITDA to provide investors with a supplemental measure of
operating performance and thus highlight trends in its core
business that may not otherwise be apparent when relying solely on
IFRS financial measures. Management also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management also
uses non-IFRS measures in order to facilitate operating performance
comparisons from period to period, prepare annual operating budgets
and assess the Company's ability to meet its capital expenditure
and working capital requirements.
Adjusted EBITDA is not a measure recognized under IFRS and does
not have a standardized meaning prescribed by IFRS. The Company
presents Adjusted EBITDA because the Company believes it
facilitates investors' use of operating performance comparisons
from period to period and company to company by backing out
potential differences caused by variations in capital structures
(affecting relative interest expense), the book amortization of
intangibles (affecting relative amortization expense) and the age
and book value of property and equipment (affecting relative
depreciation expense). The Company also presents Adjusted EBITDA
because it believes it is frequently used by securities analysts,
investors and other interested parties as a measure of financial
performance. Adjusted EBITDA as presented herein is not a
recognized measure under IFRS and should not be considered as an
alternative to operating income or net income as a measure of
operating results or an alternative to cash flows as a measure of
liquidity. Adjusted EBITDA is defined as consolidated net income
(loss) before interest, income taxes, depreciation, amortization
and other non-cash expenses deducted in determining consolidated
net income (loss) before interest, income taxes, depreciation,
amortization, other non-cash expenses and charges which include the
movement in the unrealized gains and losses on the Company's
redeemable preferred shares and warrants classified as financial
liabilities prior to the initial public offering and share based
compensation expense.
The following table reconciles net loss to Adjusted EBITDA for
Q3 2014 and Q3 2013:
|
|
Three months ended |
|
September 30, 2014 |
|
September 30,
2013 |
Net loss |
(4,000,178) |
|
(3,960,546) |
Depreciation and amortization |
379,947 |
|
387,337 |
Share-based compensation |
111,000 |
|
477,000 |
Interest Income |
(84,030) |
|
(90,675) |
Adjusted EBITDA
(1) |
(3,593,261) |
|
(3,186,884) |
|
|
|
|
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix Inc. is a renewable chemicals company specializing in
bio-based products that can be used as inputs in industrial
manufacturing for a wide range of consumer products. The Company's
products offer a reduced carbon footprint and are marketed
primarily on the basis of lower cost, stable pricing and equal or
superior performance. EcoSynthetix's lead product,
EcoSphere® biolatex® binders, is used
commercially by a number of the global top 20 manufacturers in the
coated paper and paperboard industry.
Forward Looking Statements
Certain statements in this Press Release constitute "forward
looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. These statements reflect our
current views regarding future events and operating performance and
are based on information currently available to us, and speak only
as of the date of this Press Release. These forward looking
statements involve a number of risks, uncertainties and assumptions
and should not be read as guarantees of future performance or
results, and will not necessarily be accurate indications of
whether or not such performance or results will be achieved. Those
assumptions and risks include, but are not limited to, the fact
that our results of operations and business outlook are subject to
significant risk, volatility and uncertainty. Many factors could
cause our actual results, performance or achievements to be
materially different from any future results, performance or
achievements that may be expressed or implied by such forward
looking statements, including the factors identified in the "Risk
Factors" section of the Company's Annual Information Form dated
March 31, 2014. Should one or more of
these risks or uncertainties materialize, or should assumptions
underlying the forward looking statements prove incorrect, actual
results may vary materially from those described in this Press
Release as intended, planned, anticipated, believed, estimated or
expected. Unless required by applicable securities law, we do not
intend and do not assume any obligation to update these forward
looking statements.
EcoSynthetix Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interim Consolidated Balance
Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(expressed in US dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2014 |
|
|
December 31, 2013 |
|
|
|
|
|
|
|
|
|
|
|
$ |
|
|
$ |
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash |
|
|
|
|
|
|
|
|
|
|
70,242,571 |
|
|
80,506,957 |
Accounts receivable |
|
|
|
|
|
|
|
|
|
|
2,766,090 |
|
|
3,691,791 |
Inventory |
|
|
|
|
|
|
|
|
|
|
6,314,333 |
|
|
6,470,410 |
Government grants receivable |
|
|
|
|
|
|
|
|
|
|
423,755 |
|
|
261,648 |
Prepaid expenses |
|
|
|
|
|
|
|
|
|
|
294,198 |
|
|
276,856 |
|
|
|
|
|
|
|
|
|
|
|
80,040,947 |
|
|
91,207,662 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible assets |
|
|
|
|
|
|
|
|
|
|
70,515 |
|
|
124,009 |
Property, plant and equipment |
|
|
|
|
|
|
|
|
|
|
12,042,583 |
|
|
12,775,188 |
Total assets |
|
|
|
|
|
|
|
|
|
|
92,154,045 |
|
|
104,106,859 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts payable and accrued
liabilities |
|
|
|
|
|
|
|
|
|
|
3,199,648 |
|
|
3,947,385 |
Total liabilities |
|
|
|
|
|
|
|
|
|
|
3,199,648 |
|
|
3,947,385 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shareholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common shares |
|
|
|
|
|
|
|
|
|
|
492,109,257 |
|
|
492,600,022 |
Contributed surplus |
|
|
|
|
|
|
|
|
|
|
8,011,831 |
|
|
7,661,849 |
Accumulated deficit |
|
|
|
|
|
|
|
|
|
|
(411,166,691) |
|
|
(400,102,397) |
Total shareholders'
equity |
|
|
|
|
|
|
|
|
|
|
88,954,397 |
|
|
100,159,474 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and
shareholders' equity |
|
|
|
|
|
|
|
|
|
|
92,154,045 |
|
|
104,106,859 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EcoSynthetix Inc. |
|
|
|
|
|
|
|
Interim Consolidated
Statements of Operations and Comprehensive Loss
|
|
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
For the three and nine
months ended September 30, 2014 and September 30, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
(expressed in US dollars) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended September
30, |
|
Nine months ended September
30, |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
|
$ |
|
$ |
|
$ |
|
$ |
|
|
|
|
|
|
|
|
Net sales |
4,840,892 |
|
5,416,621 |
|
14,377,604 |
|
17,070,777 |
|
|
|
|
|
|
|
|
Cost of sales |
4,346,413 |
|
4,579,748 |
|
11,947,457 |
|
14,357,296 |
|
|
|
|
|
|
|
|
Gross profit on sales |
494,479 |
|
836,873 |
|
2,430,147 |
|
2,713,481 |
|
|
|
|
|
|
|
|
Expenses |
|
|
|
|
|
|
|
Selling, general and
administrative |
3,278,090 |
|
3,450,071 |
|
9,592,862 |
|
10,175,132 |
Research and development |
1,300,597 |
|
1,438,023 |
|
4,154,854 |
|
3,936,976 |
|
4,578,687 |
|
4,888,094 |
|
13,747,716 |
|
14,112,108 |
Loss from operations |
(4,084,208) |
|
(4,051,221) |
|
(11,317,569) |
|
(11,398,627) |
|
|
|
|
|
|
|
|
Interest income |
84,030 |
|
90,675 |
|
253,275 |
|
269,903 |
Net loss and comprehensive
loss |
(4,000,178) |
|
(3,960,546) |
|
(11,064,294) |
|
(11,128,724) |
|
|
|
|
|
|
|
|
Basic and diluted loss per common
share |
(0.07) |
|
(0.07) |
|
(0.19) |
|
(0.20) |
Weighted average
number of common shares outstanding |
56,628,449 |
|
55,764,273 |
|
56,883,831 |
|
56,026,829 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EcoSynthetix Inc. |
|
|
|
|
|
|
|
Interim Consolidated Statements of
Cash Flows |
|
|
|
|
|
|
|
(Unaudited) |
|
|
|
|
|
|
|
For the three and nine
months ended September 30, 2014 and September 30, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(expressed in US dollars) |
Three months ended September
30, |
|
Nine months ended September
30, |
|
|
|
|
|
|
|
|
|
2014 |
|
2013 |
|
2014 |
|
2013 |
Cash provided by (used
in) |
$ |
|
$ |
|
$ |
|
$ |
|
|
|
|
|
|
|
|
Operating activities |
|
|
|
|
|
|
|
Net loss |
(4,000,178) |
|
(3,960,546) |
|
(11,064,294) |
|
(11,128,724) |
Items not affecting cash |
|
|
|
|
|
|
|
Depreciation
and amortization |
379,947 |
|
387,337 |
|
1,243,511 |
|
1,134,941 |
Share-based
compensation |
111,000 |
|
477,000 |
|
366,000 |
|
1,093,979 |
Changes in non-cash working
capital |
|
|
|
|
|
|
|
Accounts
receivable |
634,446 |
|
739,527 |
|
925,701 |
|
468,354 |
Inventory |
(411,741) |
|
387,133 |
|
(21,342) |
|
(329,435) |
Government
grants receivable |
21,136 |
|
(4,429) |
|
(162,107) |
|
3,169 |
Prepaid
expenses |
203,092 |
|
34,993 |
|
(17,342) |
|
(199,549) |
Accounts
payable and accrued liabilities |
(329,549) |
|
1,309,383 |
|
(747,737) |
|
1,189,479 |
Deferred
government assistance |
- |
|
(82,918) |
|
- |
|
(226,920) |
|
(3,391,847) |
|
(712,520) |
|
(9,477,610) |
|
(7,994,706) |
|
|
|
|
|
|
|
|
Investing activities |
|
|
|
|
|
|
|
Cash used for
purchase of intangible assets and property, plant and
equipment |
(8,300) |
|
(485,137) |
|
(279,993) |
|
(1,728,072) |
|
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
|
|
Exercise of common share options |
- |
|
33,260 |
|
27,930 |
|
275,957 |
Exercise of warrants |
- |
|
95,299 |
|
160,058 |
|
95,299 |
Repurchase of common shares |
(220,495) |
|
- |
|
(694,771) |
|
- |
|
(220,495) |
|
128,559 |
|
(506,783) |
|
371,256 |
|
|
|
|
|
|
|
|
Change in cash during the
period |
(3,620,642) |
|
(1,069,098) |
|
(10,264,386) |
|
(9,351,522) |
|
|
|
|
|
|
|
|
Cash - Beginning of
period |
73,863,213 |
|
84,977,872 |
|
80,506,957 |
|
93,260,296 |
Cash - End of period |
70,242,571 |
|
83,908,774 |
|
70,242,571 |
|
83,908,774 |
|
|
|
|
|
|
|
|
SOURCE EcoSynthetix Inc.